Rectal Artery Infusion Chemotherapy Combined With Anti-PD1 Antibody for MSS LARC

NCT05307198 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms

Interventions

DRUG: Oxaliplatin
PROCEDURE: Rectectomy
DRUG: Capecitabine
DRUG: Anti-PD-1 monoclonal antibody

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University